2 results
Approved WMOCompleted
The objective of this project is to assess the applicability of [11C]GMOM for in vivo imaging of the NMDA receptor.
Approved WMOWill not start
Phase 2: To evaluate progression-free survival (PFS) as the primary efficacy measure of MLN1117 plus docetaxel versus docetaxel alone in patients with advanced NSCLC